REPORTS

Let’s Pullulate and Expand Your Business

H1N1 Vaccines Market - Global Professional Analysis and Forecast to 2026

Oct 22, 2019  |  189 PAGES  |  REPORT CODE: CMM220707
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide H1N1 Vaccines market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.8% during the forecast period.

This report presents the market size and development trends by detailing the H1N1 Vaccines market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the H1N1 Vaccines market will be shown in this report. In short, this report will comprehensively reveal the characteristics of H1N1 Vaccines industry and will help you to build a panoramic view of the industrial development.

H1N1 Vaccines Market, By Type:

  • Inactivated vaccines

H1N1 Vaccines Market, By Application:

  • Swine flu

Some of the leading players are as follows:

  • BioCSL

  • Zydus Cadila

  • Novartis

  • Protein Sciences Corporation

  • AstraZeneca

  • Mitsubishi Tanabe Pharma

  • Sinovac Biotech

  • GlaxoSmithKline

  • Serum Institute

  • Sanofi Pasteur

  • Baxter International

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 H1N1 Vaccines Market: Technology Type Analysis

  • 4.1 H1N1 Vaccines Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 H1N1 Vaccines Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Inactivated vaccines

5 H1N1 Vaccines Market: Product Analysis

  • 5.1 H1N1 Vaccines Product Market Share Analysis, 2018 & 2026

  • 5.2 H1N1 Vaccines Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 H1N1 Vaccines Market: Application Analysis

  • 6.1 H1N1 Vaccines Application Market Share Analysis, 2018 & 2026

  • 6.2 H1N1 Vaccines Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Swine flu

7 H1N1 Vaccines Market: Regional Analysis

  • 7.1 H1N1 Vaccines Regional Market Share Analysis, 2018 & 2026

  • 7.2 H1N1 Vaccines Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 BioCSL

    • 9.1.1 BioCSL Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Zydus Cadila

    • 9.2.1 Zydus Cadila Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Novartis

    • 9.3.1 Novartis Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Protein Sciences Corporation

    • 9.4.1 Protein Sciences Corporation Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 AstraZeneca

    • 9.5.1 AstraZeneca Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Mitsubishi Tanabe Pharma

    • 9.6.1 Mitsubishi Tanabe Pharma Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Sinovac Biotech

    • 9.7.1 Sinovac Biotech Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 GlaxoSmithKline

    • 9.8.1 GlaxoSmithKline Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Serum Institute

    • 9.9.1 Serum Institute Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Sanofi Pasteur

    • 9.10.1 Sanofi Pasteur Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Baxter International

    • 9.11.1 Baxter International Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

 

The List of Tables and Figures (Totals 99 Figures and 145 Tables)

  • Figure Inactivated vaccines H1N1 Vaccines market, 2015 - 2026 (USD Million)

  • Figure Swine flu market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America H1N1 Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table North America H1N1 Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table North America H1N1 Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table North America H1N1 Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. H1N1 Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table U.S. H1N1 Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table U.S. H1N1 Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada H1N1 Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Canada H1N1 Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Canada H1N1 Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Europe H1N1 Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Europe H1N1 Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Europe H1N1 Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Europe H1N1 Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. H1N1 Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table U.K. H1N1 Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table U.K. H1N1 Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany H1N1 Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Germany H1N1 Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Germany H1N1 Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France H1N1 Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table France H1N1 Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table France H1N1 Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy H1N1 Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Italy H1N1 Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Italy H1N1 Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain H1N1 Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Spain H1N1 Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Spain H1N1 Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific H1N1 Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific H1N1 Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific H1N1 Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific H1N1 Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China H1N1 Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table China H1N1 Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table China H1N1 Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan H1N1 Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Japan H1N1 Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Japan H1N1 Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India H1N1 Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table India H1N1 Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table India H1N1 Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Latin America H1N1 Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Latin America H1N1 Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Latin America H1N1 Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Latin America H1N1 Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil H1N1 Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Brazil H1N1 Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Brazil H1N1 Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico H1N1 Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Mexico H1N1 Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Mexico H1N1 Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina H1N1 Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Argentina H1N1 Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Argentina H1N1 Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table MEA H1N1 Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table MEA H1N1 Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table MEA H1N1 Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table MEA H1N1 Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa H1N1 Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table South Africa H1N1 Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table South Africa H1N1 Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria H1N1 Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria H1N1 Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria H1N1 Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table BioCSL Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Zydus Cadila Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Protein Sciences Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mitsubishi Tanabe Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sinovac Biotech Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Serum Institute Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi Pasteur Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Baxter International Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top